Menu
The National Children’s Cancer Society (NCCS) secured a large quantity of Voriconazole, a drug used to treat fungal infections, for a hospital in Guatemala thanks to support from Fosun Pharma USA Inc., a new partner of the NCCS’ Michele Hertlein Global Outreach Program.
Our company embodies an entrepreneurial spirit dedicated to improving the lives of patients and their families through innovative, accessible and affordable healthcare. With global manufacturing capabilities, Fosun Pharma USA remains agile to market changes and is open to opportunities in several therapeutic categories for both branded and generic products.
Specialty Injectables
Superior quality and reliable supply of cost-effective generic injectables
Business Development
Partnerships to in-license or acquire innovative and generic products
FUSION Hub
Fosun Pharma US Innovation Hub (FUSION) invests in early-stage portfolio companies
Innovation, research and development, excellence in quality, supply reliability and patient affordability are core driving factors of Fosun Pharma USA. Based in Princeton, New Jersey, Fosun Pharma USA markets specialty injectables, develops partnerships to bring late-stage assets to the U.S. and China markets, and seeks investment opportunities with cutting-edge healthcare technologies through FUSION, our drug discovery incubator.
104 Carnegie Center Drive, Suite 204,
Princeton, NJ 08540
(609) 250-2875
info.usa@fosunpharma.com
Toll-Free (833) 291-9645
Email: GMB-SPS-Fosun@cordlogistics.com(866) 611-3762
© 2021 Fosun Pharma USA Inc. All rights reserved.